S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 3.31 USD 1.53% Market Closed
Market Cap: 216.4m USD
Have any thoughts about
Sophia Genetics SA?
Write Note

Sophia Genetics SA
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sophia Genetics SA
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Sophia Genetics SA
NASDAQ:SOPH
Net Income
-$78.5m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascom Holding AG
SIX:ASCN
Net Income
CHf15.2m
CAGR 3-Years
18%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
No Stocks Found

Sophia Genetics SA
Glance View

Market Cap
219.9m USD
Industry
Health Care

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

SOPH Intrinsic Value
4.3 USD
Undervaluation 23%
Intrinsic Value
Price
S

See Also

What is Sophia Genetics SA's Net Income?
Net Income
-78.5m USD

Based on the financial report for Dec 31, 2023, Sophia Genetics SA's Net Income amounts to -78.5m USD.

What is Sophia Genetics SA's Net Income growth rate?
Net Income CAGR 3Y
-24%

Over the last year, the Net Income growth was 10%. The average annual Net Income growth rates for Sophia Genetics SA have been -24% over the past three years .

Back to Top